Literature DB >> 20676029

HDAC inhibitors conquer Polycomb proteins.

Paul Yaswen1.   

Abstract

Mesh:

Substances:

Year:  2010        PMID: 20676029

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  3 in total

1.  (-)-Epigallocatechin-3-gallate and DZNep reduce polycomb protein level via a proteasome-dependent mechanism in skin cancer cells.

Authors:  Subhasree Roy Choudhury; Sivaprakasam Balasubramanian; Yap Ching Chew; Bingshe Han; Victor E Marquez; Richard L Eckert
Journal:  Carcinogenesis       Date:  2011-07-27       Impact factor: 4.944

2.  Quantitative analysis of EZH2 expression and its correlations with lung cancer patients' clinical pathological characteristics.

Authors:  Liyan Wan; Xiao Li; Hong Shen; Xiaoyan Bai
Journal:  Clin Transl Oncol       Date:  2012-07-24       Impact factor: 3.405

3.  Evidence of the Involvement of Spinal EZH2 in the Development of Bone Cancer Pain in Rats.

Authors:  Haoming Chen; Jianmang Yu; Lihua Hang; Shuai Li; Weikang Lu; Zhenkai Xu
Journal:  J Pain Res       Date:  2021-11-23       Impact factor: 3.133

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.